{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:13:37Z","timestamp":1789593217076,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,20]]},"DOI":"10.7759\/cureus.52605","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T08:47:30Z","timestamp":1705740450000},"source":"Crossref","is-referenced-by-count":4,"title":["A Case of Adult-Onset Still\u2019s Disease With Hypocomplementemia"],"prefix":"10.7759","author":[{"given":"Yoichi","family":"Kurosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Wakamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still's disease","volume":"14","author":"Feist E","year":"2018","unstructured":"Feist E, Mitrovic S, Fautrel B. Mechanisms, biomarkers and targets for adult-onset Still's disease. Nat Rev Rheumatol. 2018, 14:603-18. 10.1038\/s41584-018-0081-x","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli R","year":"2018","unstructured":"Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset Still's disease. J Autoimmun. 2018, 93:24-36. 10.1016\/j.jaut.2018.07.018","journal-title":"J Autoimmun"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.951535","article-title":"Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases","volume":"13","author":"Shimizu M","year":"2022","unstructured":"Shimizu M, Takei S, Mori M, Yachie A. Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases. Front Immunol. 2022, 13:10.3389\/fimmu.2022.951535","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.08.007","article-title":"Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: a systematic review","volume":"51","author":"Cota-Arce JM","year":"2021","unstructured":"Cota-Arce JM, Cota J, De Le\u00f3n-Nava MA, et al.. Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: a systematic review. Semin Arthritis Rheum. 2021, 51:1282-90. 10.1016\/j.semarthrit.2021.08.007","journal-title":"Semin Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413320","article-title":"Adult-onset Still\u2019s disease: novel biomarkers of specific subsets, disease activity, and relapsing forms","volume":"22","author":"Maranini B","year":"2021","unstructured":"Maranini B, Ciancio G, Govoni M. Adult-onset Still\u2019s disease: novel biomarkers of specific subsets, disease activity, and relapsing forms. Int J Mol Sci. 2021, 22:10.3390\/ijms222413320","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum DC","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020, 383:2255-73. 10.1056\/NEJMra2026131","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603389","article-title":"Cytokine storm in coronavirus disease 2019 and adult-onset Still\u2019s disease: similarities and differences","volume":"11","author":"Meng J","year":"2020","unstructured":"Meng J, Ma Y, Jia J, et al.. Cytokine storm in coronavirus disease 2019 and adult-onset Still\u2019s disease: similarities and differences. Front Immunol. 2020, 11:10.3389\/fimmu.2020.603389","journal-title":"Front Immunol"},{"key":"ref8","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Ohta A","year":"1992","unstructured":"Ohta A, Yamaguchi M, Tsunematsu T, et al.. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992, 19:424-30.","journal-title":"J Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.02.040","article-title":"Complement alternative pathway activation in the course of thrombotic microangiopathy associated with adult-onset Still's disease","volume":"49","author":"Carron PL","year":"2013","unstructured":"Carron PL, Cartier JC, Truche AS, Brunelle C, Cartier J, Malvezzi P, Ponard D. Complement alternative pathway activation in the course of thrombotic microangiopathy associated with adult-onset Still's disease. Transfus Apher Sci. 2013, 49:533-4. 10.1016\/j.transci.2013.02.040","journal-title":"Transfus Apher Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100833","article-title":"Hypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset still's disease: 3 cases","volume":"38","author":"Gorelik M","year":"2011","unstructured":"Gorelik M, Torok KS, Kietz DA, Hirsch R. Hypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset still's disease: 3 cases. J Rheumatol. 2011, 38:396-7. 10.3899\/jrheum.100833","journal-title":"J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14740\/jh491","article-title":"Aggressive disease and rare sequelae in a unique case of atypical hemolytic uremic syndrome secondary to adult onset Still\u2019s disease","volume":"8","author":"Khattab A","year":"2019","unstructured":"Khattab A, Yellala A, Mamadgi J, Patruni S, Kaplan R. Aggressive disease and rare sequelae in a unique case of atypical hemolytic uremic syndrome secondary to adult onset Still\u2019s disease. J Hematol. 2019, 8:64-7. 10.14740\/jh491","journal-title":"J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12708","article-title":"Thrombotic microangiopathy in a patient with adult-onset Still's disease","volume":"54","author":"Rawal S","year":"2014","unstructured":"Rawal S, Einbinder Y, Rubin L, Perl J, Trinkaus M, Teitel J, Pavenski K. Thrombotic microangiopathy in a patient with adult-onset Still's disease. Transfusion. 2014, 54:2983-7. 10.1111\/trf.12708","journal-title":"Transfusion"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio C","year":"2013","unstructured":"Ros\u00e1rio C, Zandman-Goddard G, Meyron-Holtz EG, D'Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013, 11:185. 10.1186\/1741-7015-11-185","journal-title":"BMC Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696085","article-title":"Serum complement C3 and C4 and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression","volume":"12","author":"Zinellu A","year":"2021","unstructured":"Zinellu A, Mangoni AA. Serum complement C3 and C4 and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression. Front Immunol. 2021, 12:10.3389\/fimmu.2021.696085","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1126874","article-title":"Early immune system alterations in patients with septic shock","volume":"14","author":"Tang H","year":"2023","unstructured":"Tang H, Qin S, Li Z, Gao W, Tang M, Dong X. Early immune system alterations in patients with septic shock. Front Immunol. 2023, 14:10.3389\/fimmu.2023.1126874","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.06.004","article-title":"Adult-onset Still's disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies","volume":"51","author":"Efthimiou P","year":"2021","unstructured":"Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Adult-onset Still's disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum. 2021, 51:858-74. 10.1016\/j.semarthrit.2021.06.004","journal-title":"Semin Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-022-01294-2","article-title":"Diagnosis and treatment of adult-onset Still's disease: a\u00a0concise summary of the German society of rheumatology S2\u00a0guideline","volume":"82","author":"Vordenb\u00e4umen S","year":"2023","unstructured":"Vordenb\u00e4umen S, Feist E, Rech J, et al.. Diagnosis and treatment of adult-onset Still's disease: a\u00a0concise summary of the German society of rheumatology S2\u00a0guideline. Z Rheumatol. 2023, 82:81-92. 10.1007\/s00393-022-01294-2","journal-title":"Z Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2016.08.003","article-title":"Adult-onset Still's disease: advances in the treatment","volume":"30","author":"Casta\u00f1eda S","year":"2016","unstructured":"Casta\u00f1eda S, Blanco R, Gonz\u00e1lez-Gay MA. Adult-onset Still's disease: advances in the treatment. Best Pract Res Clin Rheumatol. 2016, 30:222-38. 10.1016\/j.berh.2016.08.003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/163952","article-title":"Successful treatment with intravenous cyclophosphamide for refractory adult-onset Still\u2019s disease","volume":"2015","author":"Tsuji Y","year":"2015","unstructured":"Tsuji Y, Iwanaga N, Adachi A, et al.. Successful treatment with intravenous cyclophosphamide for refractory adult-onset Still\u2019s disease. Case Rep Rheumatol. 2015, 2015:10.1155\/2015\/163952","journal-title":"Case Rep Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2012-2","article-title":"Diagnostic and management of life-threatening adult-onset Still disease: a French nationwide multicenter study and systematic literature review","volume":"22","author":"N\u00e9el A","year":"2018","unstructured":"N\u00e9el A, Wahbi A, Tessoulin B, et al.. Diagnostic and management of life-threatening adult-onset Still disease: a French nationwide multicenter study and systematic literature review. Crit Care. 2018, 22:88. 10.1186\/s13054-018-2012-2","journal-title":"Crit Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/218649-a-case-of-adult-onset-stills-disease-with-hypocomplementemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:19Z","timestamp":1707509539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/218649-a-case-of-adult-onset-stills-disease-with-hypocomplementemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.52605","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,20]]}}}